Publicacións en colaboración con investigadores/as de Medical University of Vienna (4)

2022

  1. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    ESMO Open, Vol. 7, Núm. 2

2017

  1. A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

    Leukemia, Vol. 31, Núm. 1, pp. 107-114

2008

  1. Lenalidomide: A new therapy for multiple myeloma

    Cancer Treatment Reviews, Vol. 34, Núm. 3, pp. 283-291

2007

  1. The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

    Oncologist, Vol. 12, Núm. 3, pp. 281-290